Mahesh Krishnan - 02 Apr 2022 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC. (KDNY)

Role
Director
Signature
/s/ Kirk Schumacher, Attorney-in-Fact
Issuer symbol
KDNY
Transactions as of
02 Apr 2022
Transactions value $
$0
Form type
4
Filing time
05 Apr 2022, 18:47:39
Previous filing
29 Mar 2022
Next filing
04 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KDNY Stock Option (right to buy) Award $0 +26.6K $0.00 26.6K 02 Apr 2022 Common Stock 26.6K $16.74 Direct F1
transaction KDNY Restricted Stock (RSU)(Common Stock) Award $0 +6.6K $0.00 6.6K 02 Apr 2022 Common Stock 6.6K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option fully vests as to 1/36 of the total shares monthly beginning on May 2, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date.
F2 Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
F3 The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on April 2, 2023, until fully vested subject to the Reporting Person's provision of service to the Issuer on each vesting date.